APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Blood Products Market Outlook and Growth Opportunities 2026

25 December 2025196 pages

Choose your research edition.

Industry ResearchMedical Blood Products Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Blood Products Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Blood Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Blood Products Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Medical Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Blood Products market include Beijing Tiantan Biological Products, China Biologic Products Holdings, RAAS, HUALAN BIOLOGICAL ENGINEERING, China Resources Boya Bio-pharmaceutical Group, Takeda, Octapharma, LFB Group and Kedrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Blood Products Segment by Company

Beijing Tiantan Biological Products

China Biologic Products Holdings

RAAS

HUALAN BIOLOGICAL ENGINEERING

China Resources Boya Bio-pharmaceutical Group

Takeda

Octapharma

LFB Group

Kedrion

Grifols

CSL

BPL

Biotest

Medical Blood Products Segment by Type

Protein Products

Coagulation Factor Products

Other Blood Products

Whole Blood And Blood Components

Plasma Products

Medical Blood Products Segment by Application

Hospital

Clinic

Medical Blood Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Blood Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Blood Products significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Blood Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Blood Products industry.

Chapter 3: Detailed analysis of Medical Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Blood Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Blood Products Industry Trends Table 2. Medical Blood Products Industry Drivers Table 3. Medical Blood Products Industry Opportunities and Challenges Table 4. Medical Blood Products Industry Restraints Table 5. Global Medical Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Blood Products Revenue Share by Company (2021-2026) Table 7. Global Medical Blood Products Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Medical Blood Products Sales Volume Share by Company (2021-2026) Table 9. Global Medical Blood Products Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Medical Blood Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Blood Products Key Company Manufacturing Base & Headquarters Table 12. Global Medical Blood Products Company, Product Type & Application Table 13. Global Medical Blood Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Protein Products Table 18. Significant Companies of Coagulation Factor Products Table 19. Significant Companies of Other Blood Products Table 20. Significant Companies of Whole Blood And Blood Components Table 21. Significant Companies of Plasma Products Table 22. Global Medical Blood Products Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Medical Blood Products Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Medical Blood Products Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Medical Blood Products Sales Volume Share by Type (2021-2026) Table 26. Global Medical Blood Products Sales Volume Share by Type (2027-2032) Table 27. Global Medical Blood Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Medical Blood Products Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Medical Blood Products Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Medical Blood Products Sales Value Share by Type (2021-2026) Table 31. Global Medical Blood Products Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Global Medical Blood Products Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Medical Blood Products Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Medical Blood Products Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Medical Blood Products Sales Volume Share by Application (2021-2026) Table 38. Global Medical Blood Products Sales Volume Share by Application (2027-2032) Table 39. Global Medical Blood Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Medical Blood Products Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Medical Blood Products Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Medical Blood Products Sales Value Share by Application (2021-2026) Table 43. Global Medical Blood Products Sales Value Share by Application (2027-2032) Table 44. Global Medical Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Medical Blood Products Sales by Region (2021-2026) & (K Units) Table 46. Global Medical Blood Products Sales Market Share by Region (2021-2026) Table 47. Global Medical Blood Products Sales by Region (2027-2032) & (K Units) Table 48. Global Medical Blood Products Sales Market Share by Region (2027-2032) Table 49. Global Medical Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Medical Blood Products Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Medical Blood Products Sales Value Share by Region (2021-2026) Table 52. Global Medical Blood Products Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Medical Blood Products Sales Value Share by Region (2027-2032) Table 54. Global Medical Blood Products Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Medical Blood Products Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Medical Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Medical Blood Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Medical Blood Products Sales by Country (2021-2026) & (K Units) Table 59. Global Medical Blood Products Sales Market Share by Country (2021-2026) Table 60. Global Medical Blood Products Sales by Country (2027-2032) & (K Units) Table 61. Global Medical Blood Products Sales Market Share by Country (2027-2032) Table 62. Global Medical Blood Products Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Medical Blood Products Sales Value Market Share by Country (2021-2026) Table 64. Global Medical Blood Products Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Medical Blood Products Sales Value Market Share by Country (2027-2032) Table 66. Beijing Tiantan Biological Products Company Information Table 67. Beijing Tiantan Biological Products Business Overview Table 68. Beijing Tiantan Biological Products Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Beijing Tiantan Biological Products Medical Blood Products Product Portfolio Table 70. Beijing Tiantan Biological Products Recent Development Table 71. China Biologic Products Holdings Company Information Table 72. China Biologic Products Holdings Business Overview Table 73. China Biologic Products Holdings Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. China Biologic Products Holdings Medical Blood Products Product Portfolio Table 75. China Biologic Products Holdings Recent Development Table 76. RAAS Company Information Table 77. RAAS Business Overview Table 78. RAAS Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. RAAS Medical Blood Products Product Portfolio Table 80. RAAS Recent Development Table 81. HUALAN BIOLOGICAL ENGINEERING Company Information Table 82. HUALAN BIOLOGICAL ENGINEERING Business Overview Table 83. HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Product Portfolio Table 85. HUALAN BIOLOGICAL ENGINEERING Recent Development Table 86. China Resources Boya Bio-pharmaceutical Group Company Information Table 87. China Resources Boya Bio-pharmaceutical Group Business Overview Table 88. China Resources Boya Bio-pharmaceutical Group Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. China Resources Boya Bio-pharmaceutical Group Medical Blood Products Product Portfolio Table 90. China Resources Boya Bio-pharmaceutical Group Recent Development Table 91. Takeda Company Information Table 92. Takeda Business Overview Table 93. Takeda Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Takeda Medical Blood Products Product Portfolio Table 95. Takeda Recent Development Table 96. Octapharma Company Information Table 97. Octapharma Business Overview Table 98. Octapharma Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Octapharma Medical Blood Products Product Portfolio Table 100. Octapharma Recent Development Table 101. LFB Group Company Information Table 102. LFB Group Business Overview Table 103. LFB Group Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. LFB Group Medical Blood Products Product Portfolio Table 105. LFB Group Recent Development Table 106. Kedrion Company Information Table 107. Kedrion Business Overview Table 108. Kedrion Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Kedrion Medical Blood Products Product Portfolio Table 110. Kedrion Recent Development Table 111. Grifols Company Information Table 112. Grifols Business Overview Table 113. Grifols Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Grifols Medical Blood Products Product Portfolio Table 115. Grifols Recent Development Table 116. CSL Company Information Table 117. CSL Business Overview Table 118. CSL Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. CSL Medical Blood Products Product Portfolio Table 120. CSL Recent Development Table 121. BPL Company Information Table 122. BPL Business Overview Table 123. BPL Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. BPL Medical Blood Products Product Portfolio Table 125. BPL Recent Development Table 126. Biotest Company Information Table 127. Biotest Business Overview Table 128. Biotest Medical Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Biotest Medical Blood Products Product Portfolio Table 130. Biotest Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Medical Blood Products Distributors List Table 134. Medical Blood Products Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Medical Blood Products Product Image Figure 2. Global Medical Blood Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Blood Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Blood Products Sales (2021-2032) & (K Units) Figure 5. Global Medical Blood Products Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Medical Blood Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Protein Products Image Figure 10. Coagulation Factor Products Image Figure 11. Other Blood Products Image Figure 12. Whole Blood And Blood Components Image Figure 13. Plasma Products Image Figure 14. Global Medical Blood Products Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Medical Blood Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Medical Blood Products Sales Volume Share by Type (2021-2032) Figure 17. Global Medical Blood Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Blood Products Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Global Medical Blood Products Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Medical Blood Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Medical Blood Products Sales Volume Share by Application (2021-2032) Figure 25. Global Medical Blood Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Medical Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Medical Blood Products Sales Value Share by Application (2021-2032) Figure 28. Global Medical Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Medical Blood Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Medical Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Medical Blood Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Medical Blood Products Sales Value (2021-2032) & (US$ Million) Figure 33. North America Medical Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Medical Blood Products Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Medical Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Medical Blood Products Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Medical Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Medical Blood Products Sales Value (2021-2032) & (US$ Million) Figure 39. South America Medical Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Medical Blood Products Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Medical Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Medical Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Medical Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Medical Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Medical Blood Products Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Medical Blood Products Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Products
  • Coagulation Factor Products
  • Other Blood Products
  • Whole Blood And Blood Components
  • Plasma Products
Applications
  • Hospital
  • Clinic
Companies covered
  • Beijing Tiantan Biological Products
  • China Biologic Products Holdings
  • RAAS
  • HUALAN BIOLOGICAL ENGINEERING
  • China Resources Boya Bio-pharmaceutical Group
  • Takeda
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Blood Products Sales Value (2021-2032)
  4. 1.2.2 Global Medical Blood Products Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Blood Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Blood Products Market Dynamics
  1. 2.1 Medical Blood Products Industry Trends
  2. 2.2 Medical Blood Products Industry Drivers
  3. 2.3 Medical Blood Products Industry Opportunities and Challenges
  4. 2.4 Medical Blood Products Industry Restraints
3 Medical Blood Products Market by Company
  1. 3.1 Global Medical Blood Products Company Revenue Ranking in 2025
  2. 3.2 Global Medical Blood Products Revenue by Company (2021-2026)
  3. 3.3 Global Medical Blood Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Blood Products Average Price by Company (2021-2026)
  5. 3.5 Global Medical Blood Products Company Ranking (2024-2026)
  6. 3.6 Global Medical Blood Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Blood Products Company Product Type and Application
  8. 3.8 Global Medical Blood Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Blood Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Blood Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Blood Products Market by Type
  1. 4.1 Medical Blood Products Type Introduction
  2. 4.1.1 Protein Products
  3. 4.1.2 Coagulation Factor Products
  4. 4.1.3 Other Blood Products
  5. 4.1.4 Whole Blood And Blood Components
  6. 4.1.5 Plasma Products
  7. 4.2 Global Medical Blood Products Sales Volume by Type
  8. 4.2.1 Global Medical Blood Products Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Medical Blood Products Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Medical Blood Products Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Medical Blood Products Sales Value by Type
  12. 4.3.1 Global Medical Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Medical Blood Products Sales Value by Type (2021-2032)
  14. 4.3.3 Global Medical Blood Products Sales Value Share by Type (2021-2032)
5 Medical Blood Products Market by Application
  1. 5.1 Medical Blood Products Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Medical Blood Products Sales Volume by Application
  5. 5.2.1 Global Medical Blood Products Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Blood Products Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Medical Blood Products Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Medical Blood Products Sales Value by Application
  9. 5.3.1 Global Medical Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Medical Blood Products Sales Value by Application (2021-2032)
  11. 5.3.3 Global Medical Blood Products Sales Value Share by Application (2021-2032)
6 Medical Blood Products Regional Sales and Value Analysis
  1. 6.1 Global Medical Blood Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Blood Products Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Blood Products Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Blood Products Sales by Region (2027-2032)
  5. 6.3 Global Medical Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Blood Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Blood Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Blood Products Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Blood Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Blood Products Sales Value (2021-2032)
  12. 6.6.2 North America Medical Blood Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Blood Products Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Blood Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Blood Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Blood Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Blood Products Sales Value (2021-2032)
  21. 6.9.2 South America Medical Blood Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Blood Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Blood Products Sales Value Share by Country, 2025 VS 2032
7 Medical Blood Products Country-level Sales and Value Analysis
  1. 7.1 Global Medical Blood Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Blood Products Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Blood Products Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Blood Products Sales by Country (2027-2032)
  6. 7.4 Global Medical Blood Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Blood Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Blood Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Blood Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Blood Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Blood Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Blood Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Blood Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Blood Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Blood Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Blood Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Blood Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Blood Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Blood Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Blood Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Blood Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Blood Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Blood Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Blood Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Blood Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Blood Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Blood Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Blood Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Blood Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Blood Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Blood Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Blood Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Blood Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Blood Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Blood Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Blood Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Blood Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Blood Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Beijing Tiantan Biological Products
  2. 8.1.1 Beijing Tiantan Biological Products Company Information
  3. 8.1.2 Beijing Tiantan Biological Products Business Overview
  4. 8.1.3 Beijing Tiantan Biological Products Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Beijing Tiantan Biological Products Medical Blood Products Product Portfolio
  6. 8.1.5 Beijing Tiantan Biological Products Recent Developments
  7. 8.2 China Biologic Products Holdings
  8. 8.2.1 China Biologic Products Holdings Company Information
  9. 8.2.2 China Biologic Products Holdings Business Overview
  10. 8.2.3 China Biologic Products Holdings Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 China Biologic Products Holdings Medical Blood Products Product Portfolio
  12. 8.2.5 China Biologic Products Holdings Recent Developments
  13. 8.3 RAAS
  14. 8.3.1 RAAS Company Information
  15. 8.3.2 RAAS Business Overview
  16. 8.3.3 RAAS Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 RAAS Medical Blood Products Product Portfolio
  18. 8.3.5 RAAS Recent Developments
  19. 8.4 HUALAN BIOLOGICAL ENGINEERING
  20. 8.4.1 HUALAN BIOLOGICAL ENGINEERING Company Information
  21. 8.4.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
  22. 8.4.3 HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Product Portfolio
  24. 8.4.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
  25. 8.5 China Resources Boya Bio-pharmaceutical Group
  26. 8.5.1 China Resources Boya Bio-pharmaceutical Group Company Information
  27. 8.5.2 China Resources Boya Bio-pharmaceutical Group Business Overview
  28. 8.5.3 China Resources Boya Bio-pharmaceutical Group Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 China Resources Boya Bio-pharmaceutical Group Medical Blood Products Product Portfolio
  30. 8.5.5 China Resources Boya Bio-pharmaceutical Group Recent Developments
  31. 8.6 Takeda
  32. 8.6.1 Takeda Company Information
  33. 8.6.2 Takeda Business Overview
  34. 8.6.3 Takeda Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Takeda Medical Blood Products Product Portfolio
  36. 8.6.5 Takeda Recent Developments
  37. 8.7 Octapharma
  38. 8.7.1 Octapharma Company Information
  39. 8.7.2 Octapharma Business Overview
  40. 8.7.3 Octapharma Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Octapharma Medical Blood Products Product Portfolio
  42. 8.7.5 Octapharma Recent Developments
  43. 8.8 LFB Group
  44. 8.8.1 LFB Group Company Information
  45. 8.8.2 LFB Group Business Overview
  46. 8.8.3 LFB Group Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LFB Group Medical Blood Products Product Portfolio
  48. 8.8.5 LFB Group Recent Developments
  49. 8.9 Kedrion
  50. 8.9.1 Kedrion Company Information
  51. 8.9.2 Kedrion Business Overview
  52. 8.9.3 Kedrion Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Kedrion Medical Blood Products Product Portfolio
  54. 8.9.5 Kedrion Recent Developments
  55. 8.10 Grifols
  56. 8.10.1 Grifols Company Information
  57. 8.10.2 Grifols Business Overview
  58. 8.10.3 Grifols Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Grifols Medical Blood Products Product Portfolio
  60. 8.10.5 Grifols Recent Developments
  61. 8.11 CSL
  62. 8.11.1 CSL Company Information
  63. 8.11.2 CSL Business Overview
  64. 8.11.3 CSL Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CSL Medical Blood Products Product Portfolio
  66. 8.11.5 CSL Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BPL Medical Blood Products Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Biotest
  74. 8.13.1 Biotest Company Information
  75. 8.13.2 Biotest Business Overview
  76. 8.13.3 Biotest Medical Blood Products Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biotest Medical Blood Products Product Portfolio
  78. 8.13.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Blood Products Value Chain Analysis
  2. 9.1.1 Medical Blood Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Blood Products Sales Mode & Process
  6. 9.2 Medical Blood Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Blood Products Distributors
  9. 9.2.3 Medical Blood Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst